ArticleCancers2024

Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

Felix Peisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.